Free Paper: Cataract Surgery: Complications & Management

• Tuesday  17 September 2019 | Session Time: 14:00-16:00
  
  Venue: Free Paper Forum: Podium 1

• 14:00
• Safety and drug-release characteristics of the ocular coil: a new non-invasive drug-delivery device to prevent intraocular inflammation after cataract surgery
  Presenting Author: C.Bertens THE NETHERLANDS
• 14:06
• Safety and efficacy of a dexamethasone intracanalicular insert (0.4 mg) for the treatment of ocular pain and inflammation after cataract surgery
  Presenting Author: J. Hovanesian USA
• 14:12
• Intraoperative dexamethasone intravitreal implant in high-risk uveitic cataract phacoemulsification
  Presenting Author: L.Santana García SPAIN
• 14:18
• Mathematical models of intracameral antibiotics for postoperative endophthalmitis (POE) prophylaxis: answering lingering questions
  Presenting Author: S.Arshinoff CANADA
• 14:24
• Discussion
• 14:32
• Medical treatment after cataract surgery: evidence for a new anti-inflammatory strategy
  Presenting Author: M.Coassin ITALY
• 14:38
• Evaluating rates of cystoid macular edema after dropless cataract surgery
  Presenting Author: P.Shah USA
• 14:44
• Prevention of pseudophakic cystoid macular edema: comparison of two perioperative treatment strategies
  Presenting Author: T.Laube GERMANY
• 14:50
• Do non-steroidal anti-inflammatory drugs added to steroid treatment lower the number of unplanned postoperative visits after phacoemulsification? A two-centre comparative cohort study
  Presenting Author: B.Johansson SWEDEN
• 14:56
• Clinical outcomes, patient-reported outcomes and costs of management of pseudophakic cystoid macular oedema compared with age- and co-pathology-matched controls
  Presenting Author: H.Roberts UK
• 15:02
• Cystoid macular edema after primary anterior chamber intraocular lens implants following posterior capsule rent
  Presenting Author: S.Ti SINGAPORE
• 15:08
• Discussion
• 15:16
• Objective evaluation of anterior chamber inflammation after cataract surgery in patients who underwent intracameral injection of mydriatic drugs (Mydrane®): a pilot study
  Presenting Author: C.Cagini ITALY
• 15:22
• An open-label randomised clinical trial to evaluate the effects of Mydrane and standard topical mydriatics and anaesthetics protocol on ocular surface after cataract surgery
  Presenting Author: S.Souki SPAIN
• 15:28
• Factors influencing Mydriasert® pupillary dilation in cataract surgery
  Presenting Author: R.Romero Fontenlos UK
• 15:34
• Efficacy of a hydroxypropyl guar and hyaluronic acid ophthalmic solution on ocular discomfort after cataract surgery
  Presenting Author: E.Favuzza ITALY
• 15:40
• Conjunctival goblet cell density following cataract surgery: dry eye syndrome
  Presenting Author: E.Stangogianni Druya GREECE
• 15:46
• Discussion